NCT04791150

Rheumatologic Adverse Events and Cancer Immunotherapy

Rheumatologic Adverse Events and Immunotherapy in Oncology

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 400 (estimated)
• Sponsor: Poitiers University Hospital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

In this study, every patient with cancer who is going to be treated by immunotherapy will fill in a form. In this form, we try to determine if he presents rheumatologic complications of his immunotherapy. If the patient answers yes to one question on the form, the patient will be see in rheumatologic consultation to explore his clinical signs. The number of patients referred in consultation thanks to this questionnaire will be compared to the number of patients who would have been spontaneously referred by the oncologist. The aim of this questionnaire is to optimise the management of rheumatological effects secondary to immunotherapy.

Conditions

• Oncology
• Autoimmunity
• Arthritis
• Adverse Drug Event

Interventions

Type	Name	Description
OTHER	Fill in a form	Patient will have to fill in a form at each perfusion of immunotherapy to tell if they presents rheumatologic clinical signs

Timeline

• Start date: 2021-05-07
• Primary completion: 2022-07-07
• Completion: 2022-11-07
• First posted: 2021-03-10
• Last updated: 2021-05-10

Locations

1 site across 1 country: France